(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Giga, XPO Logistics, and iShares FTSE EPRA/NAREIT Europe.

Rank	Financial Asset	Price	Change	Updated (EST)
1	Giga (GIGA)	0.35	15.5%	2023-04-21 01:23:06
2	XPO Logistics (XPO)	43.97	7.8%	2023-04-21 13:47:14
3	iShares FTSE EPRA/NAREIT Europe (IFEU)	35.08	7.21%	2023-04-21 13:13:08
4	Lyft (LYFT)	10.43	5.95%	2023-04-21 14:46:57
5	Novavax (NVAX)	8.65	5.04%	2023-04-21 14:59:03
6	Fresenius Medical Care AG (FMS)	22.83	4.75%	2023-04-21 14:51:00
7	Novo Nordisk A/S (NVO)	172.94	4.58%	2023-04-21 14:52:39
8	Hallmark Financial Services (HALL)	6.09	4.52%	2023-04-21 05:15:08
9	HCA Holdings (HCA)	282.89	4.47%	2023-04-21 13:41:30
10	Baxter International (BAX)	45.04	4.14%	2023-04-21 13:38:28

The three biggest losers today are GSI Technology, Albemarle, and Everbridge.

Rank	Financial Asset	Price	Change	Updated (EST)
1	GSI Technology (GSIT)	1.53	-20.47%	2023-04-21 04:44:07
2	Albemarle (ALB)	173.51	-10.12%	2023-04-21 14:48:51
3	Everbridge (EVBG)	27.75	-8.64%	2023-04-21 13:37:01
4	Marathon (MARA)	8.93	-6.25%	2023-04-21 14:58:29
5	Schlumberger (SLB)	49.19	-5.36%	2023-04-21 13:45:21
6	First Foundation (FFWM)	6.72	-5.35%	2023-04-20 19:23:07
7	Xenetic Biosciences (XBIO)	0.46	-5.21%	2023-04-21 14:48:18
8	GRAVITY Co., Ltd. (GRVY)	54.46	-5.19%	2023-04-21 04:42:07
9	Freeport (FCX)	39.65	-4.15%	2023-04-21 13:40:51
10	Rio Tinto (RIO)	64.55	-4.09%	2023-04-21 14:53:08

Winners today

1. Giga (GIGA) – 15.5%

Giga-tronics Incorporated, together with its subsidiaries, develops and manufactures electronics equipment for military test and airborne operational applications in the United States and internationally. It operates through two segments, Microsource and the Giga-tronics Division. The company develops microwave components; Band Reject Filters for RADAR/EW (electronic warfare) for solving interference problems in RADAR/EW applications, as well as low noise oscillators used in shipboard and land-based self-protection systems; and RADAR filters for military fighter jet aircraft. It also designs, manufactures, and markets functional test systems for the RADAR/EW equipment of the defense electronics market. The company serves prime defense contractors, the armed services, and research institutes. Giga-tronics Incorporated was incorporated in 1980 and is headquartered in Dublin, California.

NASDAQ ended the session with Giga rising 15.5% to $0.35 on Friday, following the last session’s upward trend. NASDAQ rose 0.11% to $12,072.46, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Giga has a trailing twelve months EPS of $-0.876.

More news about Giga.

2. XPO Logistics (XPO) – 7.8%

XPO, Inc. provides freight transportation services in the United States, rest of North America, France, the United Kingdom, rest of Europe, and internationally. The company operates in two segments, North American LTL and European Transportation. The North American LTL segment provides customers with less-than-truckload (LTL) services, such as geographic density and day-definite domestic services. This segment also offers cross-border U.S., Mexico, Canada, and the Caribbean, as well as engages in the operation of trailer manufacturing. The European Transportation segment offers dedicated truckload, LTL, truck brokerage, managed transportation, last mile, freight forwarding and multimodal solutions, such as road-rail and road-short sea combinations. It provides its services to customers in various industries, such as industrial and manufacturing, retail and e-commerce, food and beverage, logistics and transportation, and consumer goods. The company was formerly known as XPO Logistics, Inc. and changed its name to XPO, Inc. in December 2022. XPO, Inc. was incorporated in 2000 and is based in Greenwich, Connecticut.

NYSE ended the session with XPO Logistics rising 7.8% to $43.97 on Friday, after five sequential sessions in a row of gains. NYSE slid 0.03% to $15,578.93, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, XPO Logistics has a trailing twelve months EPS of $1.59.

PE Ratio

XPO Logistics has a trailing twelve months price to earnings ratio of 27.65. Meaning, the purchaser of the share is investing $27.65 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.12%.

Volatility

XPO Logistics’s last week, last month’s, and last quarter’s current intraday variation average was 1.27%, 0.38%, and 2.62%.

XPO Logistics’s highest amplitude of average volatility was 1.27% (last week), 1.94% (last month), and 2.62% (last quarter).

Sales Growth

XPO Logistics’s sales growth is negative 46.2% for the ongoing quarter and negative 39.9% for the next.

Moving Average

XPO Logistics’s value is way above its 50-day moving average of $34.59 and way above its 200-day moving average of $33.45.

Yearly Top and Bottom Value

XPO Logistics’s stock is valued at $43.97 at 17:32 EST, under its 52-week high of $45.06 and way higher than its 52-week low of $24.76.

More news about XPO Logistics.

3. iShares FTSE EPRA/NAREIT Europe (IFEU) – 7.21%

NASDAQ ended the session with iShares FTSE EPRA/NAREIT Europe rising 7.21% to $35.08 on Friday while NASDAQ jumped 0.11% to $12,072.46.

Earnings Per Share

As for profitability, iShares FTSE EPRA/NAREIT Europe has a trailing twelve months EPS of $3.47.

More news about iShares FTSE EPRA/NAREIT Europe.

4. Lyft (LYFT) – 5.95%

Lyft, Inc. operates a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. The company operates multimodal transportation networks that offer riders personalized and on-demand access to various mobility options. It provides Ridesharing Marketplace, which connects drivers with riders; Express Drive, a flexible car rentals program for drivers; Lyft Rentals that provides vehicles for long-distance trips; and a network of shared bikes and scooters in various cities to address the needs of riders for short trips. The company also integrates third-party public transit data into the Lyft app to offer riders various transportation options. In addition, it offers access to autonomous vehicles; centralized tools and enterprise transportation solutions, such as concierge transportation solutions for organizations; Lyft Pink subscription plans; Lyft Pass commuter programs; first-mile and last-mile services; and university safe rides programs. The company was formerly known as Zimride, Inc. and changed its name to Lyft, Inc. in April 2013. Lyft, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

NASDAQ ended the session with Lyft rising 5.95% to $10.43 on Friday, after three consecutive sessions in a row of losses. NASDAQ jumped 0.11% to $12,072.46, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Lyft has a trailing twelve months EPS of $-4.39.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -183.19%.

Volatility

Lyft’s last week, last month’s, and last quarter’s current intraday variation average was 0.33%, 0.13%, and 3.86%.

Lyft’s highest amplitude of average volatility was 1.50% (last week), 2.69% (last month), and 3.86% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Lyft’s stock is considered to be overbought (>=80).

Sales Growth

Lyft’s sales growth is 12.1% for the current quarter and 9.5% for the next.

More news about Lyft.

5. Novavax (NVAX) – 5.04%

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax rising 5.04% to $8.65 on Friday, after three sequential sessions in a row of losses. NASDAQ jumped 0.11% to $12,072.46, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Novavax has a trailing twelve months EPS of $-8.42.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Novavax’s EBITDA is -0.17.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Novavax’s stock is considered to be overbought (>=80).

More news about Novavax.

6. Fresenius Medical Care AG (FMS) – 4.75%

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

NYSE ended the session with Fresenius Medical Care AG rising 4.75% to $22.83 on Friday while NYSE slid 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Fresenius Medical Care AG has a trailing twelve months EPS of $1.26.

PE Ratio

Fresenius Medical Care AG has a trailing twelve months price to earnings ratio of 18.12. Meaning, the purchaser of the share is investing $18.12 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.08%.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 804407 which is 17.5% below its average volume of 975070.

Moving Average

Fresenius Medical Care AG’s worth is way above its 50-day moving average of $20.22 and way higher than its 200-day moving average of $17.90.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 19.4B for the twelve trailing months.

More news about Fresenius Medical Care AG.

7. Novo Nordisk A/S (NVO) – 4.58%

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NYSE ended the session with Novo Nordisk A/S rising 4.58% to $172.94 on Friday, after three consecutive sessions in a row of gains. NYSE fell 0.03% to $15,578.93, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $3.58.

PE Ratio

Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 48.31. Meaning, the purchaser of the share is investing $48.31 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72%.

Sales Growth

Novo Nordisk A/S’s sales growth is 33.5% for the present quarter and 35.2% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Novo Nordisk A/S’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $172.94 at 17:32 EST, above its 52-week high of $169.88.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 47.6% and 55.1%, respectively.

More news about Novo Nordisk A/S.

8. Hallmark Financial Services (HALL) – 4.52%

Hallmark Financial Services, Inc. underwrites, markets, distributes, and services property/casualty insurance products to businesses and individuals in the United States. The company operates through Specialty Commercial, Standard Commercial, and Personal segments. The Specialty Commercial segment offers primary and excess commercial vehicle insurance products and services; primary and excess liability, excess public entity liability, and E&S package and garage liability insurance products and services; primary and excess commercial property insurance for catastrophe and non-catastrophe exposures; healthcare and financial lines professional liability insurance products and services primarily for businesses, medical professionals, medical facilities, and senior care facilities; and satellite launch property/casualty insurance products and services, as well as various specialty programs. The Standard Commercial segment provides package and monoline property/casualty insurance products and services. The Personal segment offers non-standard personal automobile and renters insurance products and services. It markets its insurance products through independent general agents, retail agents, and specialty brokers. The company was incorporated in 1987 and is headquartered in Dallas, Texas.

NASDAQ ended the session with Hallmark Financial Services jumping 4.52% to $6.09 on Friday, following the last session’s upward trend. NASDAQ jumped 0.11% to $12,072.46, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Hallmark Financial Services has a trailing twelve months EPS of $-68.52.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -114.43%.

More news about Hallmark Financial Services.

9. HCA Holdings (HCA) – 4.47%

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

NYSE ended the session with HCA Holdings jumping 4.47% to $282.89 on Friday, following the last session’s downward trend. NYSE fell 0.03% to $15,578.93, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, HCA Holdings has a trailing twelve months EPS of $19.14.

PE Ratio

HCA Holdings has a trailing twelve months price to earnings ratio of 14.78. Meaning, the purchaser of the share is investing $14.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 965.25%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HCA Holdings’s stock is considered to be oversold (<=20).

Earnings Before Interest, Taxes, Depreciation, and Amortization

HCA Holdings’s EBITDA is 23.6.

More news about HCA Holdings.

10. Baxter International (BAX) – 4.14%

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.

NYSE ended the session with Baxter International jumping 4.14% to $45.04 on Friday, following the last session’s downward trend. NYSE fell 0.03% to $15,578.93, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Baxter International has a trailing twelve months EPS of $-4.87.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.25%.

Volatility

Baxter International’s last week, last month’s, and last quarter’s current intraday variation average was 0.12%, 0.50%, and 1.58%.

Baxter International’s highest amplitude of average volatility was 0.82% (last week), 1.24% (last month), and 1.58% (last quarter).

More news about Baxter International.

Losers Today

1. GSI Technology (GSIT) – -20.47%

GSI Technology, Inc., a fabless semiconductor company, designs, develops, and markets semiconductor memory solutions to networking, industrial, medical, aerospace, and military customers in the United States, China, Singapore, Germany, the Netherlands, and internationally. The company's associative processing unit products offers applications using similarity search in visual search queries for ecommerce, computer vision, drug discovery, cyber security, and service markets. In addition, it offers static random access memory (SRAM) products, such as SyncBurst for microprocessor cache and other applications; No Bus Turnaround SRAMs to address the needs of networking and telecom applications; SigmaQuad and SigmaDDR products for density and random transaction rate requirements of networking and telecom applications; Low Latency DRAMs a solution for advanced data networking applications; Asynchronous, a main memory for small cache-less embedded processors for industrial electronics, measurement systems and cost-sensitive networking equipment, and other applications; and specialty SRAMs. The company also provide radiation-hardened and radiation-tolerant SRAMs for aerospace and military applications, such as networking satellites and missiles. Its products are used as components in our OEM customers' products, including routers, switches and other networking and telecommunications products; military and aerospace applications, such as radar and guidance systems and satellites; audio/video processing; test and measurement applications consisting of high-speed testers; and automotive applications, such as smart cruise control; and medical applications, including ultrasound and CAT scan equipment. The company markets its products through a network of independent sales representatives and distributors. GSI Technology, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

NASDAQ ended the session with GSI Technology dropping 20.47% to $1.53 on Friday while NASDAQ rose 0.11% to $12,072.46.

Earnings Per Share

As for profitability, GSI Technology has a trailing twelve months EPS of $-0.59.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.71%.

More news about GSI Technology.

2. Albemarle (ALB) – -10.12%

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

NYSE ended the session with Albemarle sliding 10.12% to $173.51 on Friday while NYSE slid 0.03% to $15,578.93.

Earnings Per Share

As for profitability, Albemarle has a trailing twelve months EPS of $22.84.

PE Ratio

Albemarle has a trailing twelve months price to earnings ratio of 7.6. Meaning, the purchaser of the share is investing $7.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.23%.

Yearly Top and Bottom Value

Albemarle’s stock is valued at $173.51 at 17:32 EST, below its 52-week low of $185.15.

More news about Albemarle.

3. Everbridge (EVBG) – -8.64%

Everbridge, Inc. operates as a software company that enables customers to anticipate, mitigate, respond to, and recover from critical events in North America and internationally. The company offers Critical Event Management, a SaaS based platform, which offers various software applications for organizations for safeguarding business operations, people resilience, digital operations, smart security, and public safety. The Company's enterprise applications include Mass Notification, Safety Connection, IT Alerting, Visual Command Center, Public Warning, Community Engagement, Risk Center, Crisis Management, CareConverge, Control Center, 911 Connect, Travel Risk Management, SnapComms, and E911 for automating various critical event management processes. It serves enterprises, small businesses, non-profit organizations, educational institutions, and government agencies in technology, energy, financial services, healthcare and life sciences, manufacturing, media and entertainment, retail, higher education, and professional services industries. The company was formerly known as 3n Global, Inc. and changed its name to Everbridge, Inc. in April 2009. The company was founded in 2002 and is based in Burlington, Massachusetts.

NASDAQ ended the session with Everbridge falling 8.64% to $27.75 on Friday, after two successive sessions in a row of losses. NASDAQ jumped 0.11% to $12,072.46, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Everbridge has a trailing twelve months EPS of $-1.73.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.27%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 750% and 966.7%, respectively.

Yearly Top and Bottom Value

Everbridge’s stock is valued at $27.75 at 17:32 EST, way under its 52-week high of $50.80 and way above its 52-week low of $24.10.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Everbridge’s stock is considered to be overbought (>=80).

More news about Everbridge.

4. Marathon (MARA) – -6.25%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon dropping 6.25% to $8.93 on Friday while NASDAQ rose 0.11% to $12,072.46.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-5.52.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -128.6%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 61.5% and 100%, respectively.

More news about Marathon.

5. Schlumberger (SLB) – -5.36%

Schlumberger Limited engages in the provision of technology for the energy industry worldwide. The company operates through four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems. The company provides field development and hydrocarbon production, carbon management, integration of adjacent energy systems; reservoir interpretation and data processing services for exploration data; and well construction and production improvement services and products. It also offers subsurface geology and fluids evaluation information; open and cased hole services; exploration and production pressure, and flow-rate measurement services; and pressure pumping, well stimulation, and coiled tubing equipment solutions. In addition, the company offers mud logging, directional drilling, measurement-while-drilling, and logging-while-drilling services, as well as engineering support services; supplies drilling fluid systems; designs, manufactures, and markets roller cone and fixed cutter drill bits; bottom-hole-assembly and borehole enlargement technologies; well cementing products and services; well planning, well drilling, engineering, supervision, logistics, procurement, and contracting of third parties, as well as drilling rig management solutions; and drilling equipment and services, as well as land drilling rigs and related services. Further, it provides artificial lift production equipment and optimization services; supplies packers, safety valves, sand control technology, and various intelligent well completions technology and equipment; designs and manufactures valves, chokes, actuators, and surface trees; and OneSubsea an integrated solutions, products, systems, and services, including wellheads, subsea trees, manifolds and flowline connectors, control systems, connectors, and services. The company was formerly known as Socie´te´ de Prospection E´lectrique. Schlumberger Limited was founded in 1926 and is based in Houston, Texas.

NYSE ended the session with Schlumberger dropping 5.36% to $49.19 on Friday, following the last session’s downward trend. NYSE slid 0.03% to $15,578.93, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Schlumberger (slb) Q1 earnings and revenues surpass estimatesWhile Schlumberger has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Schlumberger (slb) Q1 earnings: taking a look at key metrics versus estimatesFor the quarter ended March 2023, Schlumberger (SLB Quick QuoteSLB – Free Report) reported revenue of $7.74 billion, up 29.8% over the same period last year. , Here is how Schlumberger performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, Schlumberger has a trailing twelve months EPS of $2.42.

PE Ratio

Schlumberger has a trailing twelve months price to earnings ratio of 20.32. Meaning, the purchaser of the share is investing $20.32 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.99%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Schlumberger’s stock is considered to be oversold (<=20).

Moving Average

Schlumberger’s worth is below its 50-day moving average of $51.54 and above its 200-day moving average of $46.41.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Schlumberger’s EBITDA is 42.41.

More news about Schlumberger.

6. First Foundation (FFWM) – -5.35%

First Foundation Inc., through its subsidiaries, provides personal banking, business banking, and private wealth management services in the United States. It operates through two segments, Banking and Wealth Management. The company offers a range of bank deposit products, including personal and business checking accounts, savings accounts, interest-bearing negotiable order of withdrawal accounts, money market accounts, and time certificate of deposits; and loan products consisting of multifamily and single family residential real estate loans, commercial real estate loans, and commercial term loans and line of credits, as well as consumer loans, such as personal installment loans and line of credits, and home equity line of credits. It also provides various specialized services comprising trust services, internet and mobile banking, remote deposit capture services, merchant credit card services, ATM cards, Visa debit cards, and business sweep accounts, as well as insurance brokerage services and equipment financing solutions. In addition, the company offers investment management and financial planning services; treasury management services; advisory and coordination services in the areas of estate planning, retirement planning, and charitable and business ownership issues; and financial, investment, and economic advisory and related services. Further, it provides support services, including the processing and transmission of financial and economic data for charitable organizations. The company operates through a network of 28 branch offices and 3 loan production offices in California, Nevada, Texas, and Hawaii. First Foundation Inc. was founded in 1985 and is headquartered in Dallas, Texas.

NASDAQ ended the session with First Foundation sliding 5.35% to $6.72 on Friday while NASDAQ jumped 0.11% to $12,072.46.

Earnings Per Share

As for profitability, First Foundation has a trailing twelve months EPS of $2.11.

PE Ratio

First Foundation has a trailing twelve months price to earnings ratio of 3.18. Meaning, the purchaser of the share is investing $3.18 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.05%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 366.39M for the twelve trailing months.

Moving Average

First Foundation’s worth is way under its 50-day moving average of $10.83 and way under its 200-day moving average of $15.67.

More news about First Foundation.

7. Xenetic Biosciences (XBIO) – -5.21%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences falling 5.21% to $0.46 on Friday while NASDAQ jumped 0.11% to $12,072.46.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-0.51.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.9%.

Moving Average

Xenetic Biosciences’s value is below its 50-day moving average of $0.49 and way under its 200-day moving average of $0.57.

More news about Xenetic Biosciences.

8. GRAVITY Co., Ltd. (GRVY) – -5.19%

Gravity Co., Ltd. develops and publishes online and mobile games in South Korea, Taiwan, Thailand, and Japan. The company offers a massively multiplayer online role-playing game, including Ragnarok Online, Dragonica, Ragnarok Online II, and Ragnarok Prequel II. Its mobile games portfolio includes Ragnarok M: Eternal Love; Ragnarok Origin; Ragnarok X: Next Generation; the Labyrinth of Ragnarok; Ragnarok Poring Merge; Tera Classic; Ragnarok: The Lost Memories; Sadako M; NBA: Rise To Stardom; Milkmaid Of The Milky Way; and Paladog Tactics. The company also provides console games, such as Ragnarok DS for Nintendo DS; Ragnarok: The Princess of Light and Darkness for PlayStation Portable; Ragnarok Odyssey for PlayStation Vita; Double Dragon II for Xbox 360; Ragnarok Odyssey Ace for PlayStation Vita and PlayStation 3; and GRANDIA HD Collection for Nintendo Switch. In addition, it offers games for IPTV, including Pororo: The Little Penguin; and markets dolls, stationery, food, and other character-based merchandises, as well as game manuals, monthly magazines, and other publications. Further, the company provides system development and maintenance services, as well as system integration services to third parties. As of December 31, 2021, it owned 156 registered domain names. The company was incorporated in 2000 and is headquartered in Seoul, South Korea. Gravity Co., Ltd. is a subsidiary of GungHo Online Entertainment, Inc.

NASDAQ ended the session with GRAVITY Co., Ltd. falling 5.19% to $54.46 on Friday while NASDAQ rose 0.11% to $12,072.46.

Earnings Per Share

As for profitability, GRAVITY Co., Ltd. has a trailing twelve months EPS of $9.24.

PE Ratio

GRAVITY Co., Ltd. has a trailing twelve months price to earnings ratio of 5.89. Meaning, the purchaser of the share is investing $5.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.62%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 20.4%, now sitting on 384.1B for the twelve trailing months.

Volume

Today’s last reported volume for GRAVITY Co., Ltd. is 14160 which is 39.73% below its average volume of 23495.

More news about GRAVITY Co., Ltd..

9. Freeport (FCX) – -4.15%

Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia. It primarily explores for copper, gold, molybdenum, silver, and other metals, as well as oil and gas. The company's assets include the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, and Miami in Arizona; Tyrone and Chino in New Mexico; and Henderson and Climax in Colorado, North America, as well as Cerro Verde in Peru and El Abra in Chile. It also operates a portfolio of oil and gas properties primarily located in offshore California and the Gulf of Mexico. The company was formerly known as Freeport-McMoRan Copper & Gold Inc. and changed its name to Freeport-McMoRan Inc. in July 2014. Freeport-McMoRan Inc. was incorporated in 1987 and is headquartered in Phoenix, Arizona.

NYSE ended the session with Freeport falling 4.15% to $39.65 on Friday, after two sequential sessions in a row of losses. NYSE fell 0.03% to $15,578.93, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Freeport has a trailing twelve months EPS of $2.39.

PE Ratio

Freeport has a trailing twelve months price to earnings ratio of 16.59. Meaning, the purchaser of the share is investing $16.59 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.7%.

Volatility

Freeport’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.08%, a positive 0.44%, and a positive 1.80%.

Freeport’s highest amplitude of average volatility was 2.07% (last week), 1.33% (last month), and 1.80% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.6%, now sitting on 22.78B for the twelve trailing months.

Moving Average

Freeport’s value is under its 50-day moving average of $40.60 and way above its 200-day moving average of $35.42.

More news about Freeport.

10. Rio Tinto (RIO) – -4.09%

Rio Tinto Group engages in exploring, mining, and processing mineral resources worldwide. The company operates through Iron Ore, Aluminium, Copper, and Minerals Segments. It offers aluminum, copper, iron ore, diamonds, gold, borates, titanium dioxide, salt, silver, molybdenum, and lithium. The company also owns and operates open pit and underground mines, refineries, smelters, and concentrator facilities, as well as power stations, research, and service facilities. Rio Tinto Group was founded in 1873 and is headquartered in London, the United Kingdom.

NYSE ended the session with Rio Tinto dropping 4.09% to $64.55 on Friday, after five consecutive sessions in a row of losses. NYSE slid 0.03% to $15,578.93, after two successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Rio Tinto has a trailing twelve months EPS of $7.83.

PE Ratio

Rio Tinto has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing $8.24 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.02%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 15.2%, now sitting on 55.55B for the twelve trailing months.

Volume

Today’s last reported volume for Rio Tinto is 6089520 which is 83.87% above its average volume of 3311750.

More news about Rio Tinto.

Stay up to date with our winners and losers daily report